Charles A. Deignan's Insider Trades & SAST Disclosures

Charles A. Deignan's most recent trade in Clearside Biomedical Inc was a trade of 200,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 18, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Clearside Biomedical Inc
A. Deignan Charles Chief Financial Officer 18 Jan 2024 200,000 200,000 - - Employee Stock Option (right to buy)
Clearside Biomedical Inc
Deignan Charles A. Chief Financial Officer 18 Jan 2024 12,900 384,662 (0%) 0% 1.3 16,512 Common Stock
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 04 Jan 2023 187,500 187,500 - - Employee Stock Option (right to buy)
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 20 Dec 2022 23,636 0 - - Employee Stock Option (right to buy)
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 20 Dec 2022 23,636 377,502 (0%) 0% 0.4 9,454 Common Stock
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 18 Jan 2022 138,750 138,750 - - Stock Option (Right to Buy)
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 18 Jan 2022 46,250 362,699 (0%) 0% 0 Common Stock
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 21 Sep 2021 2,800 316,449 (0%) 0% 6.4 17,948 Common Stock
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 21 Jun 2021 2,938 319,249 (0%) 0% 4.4 12,839 Common Stock
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 18 Jan 2021 195,640 195,640 - - Stock Option (Right to Buy)
Clearside Biomedical Inc
Charles A. Deignan Chief Financial Officer 18 Jan 2021 96,360 322,187 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades